UBS Group AG - NRX PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

NRX PHARMACEUTICALS INC's ticker is NRXPW and the CUSIP is 629444118. A total of 5 filers reported holding NRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$625
+3.5%
7,812
+132.8%
0.00%–
Q1 2023$604–3,356
+1704.3%
0.00%–
Q2 2022$0
-100.0%
186
-95.7%
0.00%–
Q4 2021$8,000
-27.3%
4,358
+83.6%
0.00%–
Q3 2021$11,000–2,373–0.00%–
 Download
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
UBS Group AG 186$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,678$2,0000.00%
Tower Research Capital LLC (TRC) 15$00.00%
Yakira Capital Management, Inc. 17,129$2,0000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders